Jaka jest cena za Impact BioMedical Inc. (IBO)

Cena za Impact BioMedical Inc. (IBO) wynosi $0.4587

Jaka jest kapitalizacja rynkowa dla Impact BioMedical Inc. (IBO)

Kapitalizacja rynkowa dla Impact BioMedical Inc. (IBO) wynosi $49.46M

Impact BioMedical Inc. (IBO) Historia Cen

Houston, Texas-based Impact BioMedical Inc., founded in 2018, focuses on discovering and developing innovative products and therapeutic options for both specialty biopharmaceuticals and consumer healthcare markets. The company features several key technologies: its "Linebacker" platform utilizes small molecule electrophilically enhanced polyphenol compounds with potential applications in treating cancer, inflammatory diseases, and neurological conditions. Additionally, "Laetose" technology, a unique blend of sugar and inositol, is designed to counteract the inflammatory and metabolic responses usually triggered by sugar consumption. Impact BioMedical also creates "functional fragrance formulations," which are a series of fragrances incorporating specialized botanical ingredients for antimicrobial purposes, or as active additives in items like insect repellents, cleaning products, personal care items, and fabrics. Rounding out its offerings is the "Equivir/Equivir G" technology, a distinctive mix of polyphenols that has exhibited antiviral properties, suitable for use in health supplements and medications.

Rok	Wydajność
2026 (TTM)	10.03%
2025	-74.29%
2024	0.00%

Rok

Wydajność

2026 (TTM)

10.03%

2025

-74.29%

2024

0.00%

Firma	Cena akcji	Zmiana 1r%	Kraj
Vertex Pharmaceuticals Incorporated VRTX.US	$539.14	35.65%	US
Argenx SE ARGX.US	$1.04K	56.21%	NL
CSL Limited CSL.AX	$118.42	-18.43%	AU
Lonza Group AG LONN.SW	$761.87	8.65%	CH
Moderna, Inc. MRNA.US	$130.43	397.46%	US

Firma

Cena akcji

Zmiana 1r%

Kraj